T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice
about
Tuberculosis and HIV co-infectionEngineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem/progenitor cells in humanized BLT miceTargeted DNA mutagenesis for the cure of chronic viral infectionsThe development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemicAnimal Models for HIV Cure ResearchTargeting Th17 Cells with Small Molecules and Small Interference RNAAnimal models to study Mycobacterium tuberculosis and HIV co-infectionStudies of retroviral infection in humanized miceThe involvement of microRNAs in neurodegenerative diseasesLipid nanoparticles as carriers for RNAi against viral infections: current status and future perspectivesRecent developments in human immunodeficiency virus-1 latency researchNew generation humanized mice for virus research: comparative aspects and future prospectsGene therapy strategies for HIV/AIDS: preclinical modeling in humanized miceAttachment of cell-binding ligands to arginine-rich cell-penetrating peptides enables cytosolic translocation of complexed siRNA.Silencing Viral MicroRNA as a Novel Antiviral Therapy?Targeted Delivery of Small Interfering RNA to Human Dendritic Cells To Suppress Dengue Virus Infection and Associated Proinflammatory Cytokine ProductionNanomedicines based on recombinant fusion proteins for targeting therapeutic siRNA oligonucleotides.Knocking down disease: a progress report on siRNA therapeuticsCurrent prospects for RNA interference-based therapiesCell-penetrating peptide-mediated delivery of TALEN proteins via bioconjugation for genome engineeringA novel class of anti-HIV agents with multiple copies of enfuvirtide enhances inhibition of viral replication and cellular transmission in vitroAnimal models for HIV/AIDS researchClosing the door to human immunodeficiency virus.Anti-HBV efficacy of combined siRNAs targeting viral gene and heat shock cognate 70.Asymmetric peptide dendrimers are effective linkers for antibody-mediated delivery of diverse payloads to b cells in vitro and in vivo.Unique biological properties of catalytic domain directed human anti-CAIX antibodies discovered through phage-display technologyHuman allograft rejection in humanized mice: a historical perspectivePreintegration HIV-1 inhibition by a combination lentiviral vector containing a chimeric TRIM5 alpha protein, a CCR5 shRNA, and a TAR decoy.Evolution of the HIV-1 env gene in the Rag2-/- gammaC-/- humanized mouse modelPolyethylene glycol-poly(ε-benzyloxycarbonyl-l-lysine)-conjugated VEGF siRNA for antiangiogenic gene therapy in hepatocellular carcinoma.Intranasal drug delivery of small interfering RNA targeting Beclin1 encapsulated with polyethylenimine (PEI) in mouse brain to achieve HIV attenuation.A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model.A Nonpolycationic Fully Proteinaceous Multiagent System for Potent Targeted Delivery of siRNA.Lung endothelial HO-1 targeting in vivo using lentiviral miRNA regulates apoptosis and autophagy during oxidant injury.Drug delivery-mediated control of RNA immunostimulationVersatile RNA interference nanoplatform for systemic delivery of RNAs.Aptamer-targeted cell-specific RNA interferenceSelection of potent non-toxic inhibitory sequences from a randomized HIV-1 specific lentiviral short hairpin RNA library.Evaluation of efficacy, biodistribution, and inflammation for a potent siRNA nanoparticle: effect of dexamethasone co-treatment.RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice
P2860
Q21131403-BC55CD72-F296-4AF4-8487-40235A65D03CQ21133769-2DB26583-6D75-4DEF-9811-90C80B5A577CQ24620150-7A2B2D3A-7550-4B39-9D3D-64D190C98036Q24655011-1EE11F8A-4EF6-4CCA-AB0F-C6A3D66CEBDEQ26767476-04DDBA84-59C2-448E-A870-F0B655DACDF8Q26770523-46D54C2A-48A6-4C45-BFFA-F01680E38FFCQ26824653-DC54A694-55BE-4198-BACD-4D316D923A1BQ26849806-764EAD7D-54B1-4A8C-A87F-84857CD0B98BQ26858788-FBE4963D-1B2F-466E-9C60-C7230DA779A9Q26859021-DF262D46-41A5-4225-8A12-1741E6E67A14Q27013114-FB37DFEF-A4FB-404C-8ADC-8921B07FBABAQ27014786-0CC88E3B-1D14-4360-B913-9EF50F5393EBQ27022347-B6A2FCD3-08CF-43FD-80DC-B9685D463626Q27318674-175CEE62-C3A9-4E98-BD67-FAD20CA877A9Q27488437-38EB4872-93F2-4AB1-B5FB-4E23910A6D18Q27490919-E8F87236-1299-450F-9F35-E1DBD5B0FF30Q27692125-5612510B-1834-405B-B4C6-953EFB98A8B8Q28082939-748FA255-8AF9-4855-AD6D-03D0BD8EF5DAQ28235733-8CBA7E2A-0461-4D31-9517-FCD3E5D95541Q28538875-4F799004-7946-46A8-914F-FEB3889BDA42Q28728917-2C9E2D36-D3FF-4C55-91FF-B8E4A8E8696AQ30423656-44CCE33D-8FA3-441E-BEF5-80D9895A2D63Q30428089-B55254AE-15F0-4433-9BCF-5F155A9E7BFFQ30531035-74CFE68E-AF35-4897-B5CA-545DA1CE920BQ30825112-0AE54210-AA47-4DC6-A403-7C9797467B86Q33540178-A654CBC6-6AF5-4A86-A495-61AAB510564EQ33577374-BAD5691D-358F-41F3-969A-6A13899A9E42Q33622741-14AFBB4C-58AC-4448-ABE2-8D723604337AQ33676640-B67E358A-6054-49DA-8565-F74E35B238A6Q33686536-5E59595C-4343-429A-8D35-A07186376D34Q33687594-57ACE3D0-AB43-4D3F-8F93-F53495942648Q33697336-42B48C1A-C784-45E2-A6D5-D1081DC313F0Q33701022-B7BB88A0-9C60-4026-8DA7-9B6A050D3E63Q33713713-777C28EE-74E9-4385-BF20-74899E42C1D0Q33713938-65D5E60E-D254-4432-B59E-C06C18DA422EQ33716038-B1FE82DA-0F4F-4481-9E00-CBAB7E37BF35Q33717239-A5C5F64F-A5F9-430F-B350-67930A76CC5BQ33719287-BF85CA9A-81B0-4AE1-A581-4A57DD5EEB94Q33730481-C498AA47-86FD-4172-A987-3B809F5D9DDDQ33730699-8B94AD84-B135-40B2-A51C-072AB274388D
P2860
T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice
@ast
T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice
@en
T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice
@nl
type
label
T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice
@ast
T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice
@en
T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice
@nl
prefLabel
T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice
@ast
T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice
@en
T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice
@nl
P2093
P2860
P3181
P1433
P1476
T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice
@en
P2093
Amale Laouar
Dale L Greiner
Georg H Fey
Haoquan Wu
Hong-Seok Ban
Ji-Hoon Jeong
Jiahong Yao
Katsuyoshi Habiro
Kuen-Yong Lee
Leonard D Shultz
P2860
P304
P3181
P356
10.1016/J.CELL.2008.06.034
P407
P577
2008-08-22T00:00:00Z